Antibody Drug Conjugates Market Size, Share & Industry Analysis, By Product/Target Family (HER2-directed ADCs, Nectin-4-directed ADCs, TROP2-directed ADCs, CD30-directed ADCs, and Others), By Payload Class (Topoisomerase I Inhibitor ADCs, Microtubule Inhibitor ADCs, and Others), By Disease Indication (Breast Cancer, Urothelial Cancer, Lymphoma, Lung Cancer, Ovarian Cancer, and Others), By Route of Administration (Intravenous and Others), By End User (Hospitals, Cancer Specialty Centers, Academic & Research Hospitals, Ambulatory Infusion Centers, and Others), and Regional Forecast, 2026-2034